Ambulatory For Individual Practice For Specialized Medical Care Kardio EOOD
- Address
- Bulevard Republika 15, 9020 Varna, Bulgaria
Cardiovascular Diseases
The research portfolio at Ambulatory For Individual Practice For Specialized Medical Care Kardio EOOD includes studies in cardiovascular medicine focused on people with atherosclerotic cardiovascular disease and elevated lipoprotein(a). These trials are designed to assess whether new treatments can reduce the risk of serious heart-related events and improve long-term outcomes.
- Testing a therapy aimed at lowering the chance of heart attack, urgent revascularization, and cardiovascular death
- Evaluating treatment effectiveness in patients with established atherosclerotic cardiovascular disease
This area reflects a strong interest in preventive care and in finding better options for patients at high cardiovascular risk.
Nutritional and Metabolic Diseases
Clinical trials at this site also address nutritional and metabolic disorders, especially overweight, obesity, and type 2 diabetes. The research is centered on helping people manage body weight and improve blood sugar control through new treatment approaches.
- Studying therapies for weight reduction in adults with excess body weight
- Assessing medicines intended to improve glycemic control in type 2 diabetes
These studies aim to support better disease management and to expand options for patients who need more effective control of metabolic health conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ambulatory For Individual Practice For Specialized Medical Care Kardio EOOD
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Dose-Response Study of NNC0487-0111 in Type 2 Diabetes Patients Inadequately Controlled with Metformin and/or SGLT2 Inhibitors | Novo Nordisk A/S | Phase II | Not Recruiting | Jul 2024 | Oct 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin Propanediol | 1 | Unknown | 2024-07-26 | 2024-07-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.